Niagen Bioscience Investor Relations Material
Latest events
Q2 2025
Niagen Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Niagen Bioscience Inc
Access all reports
ChromaDex Corporation is a biosciences company that develops and markets ingredients and consumer products based on nicotinamide riboside and other proprietary compounds. Its product portfolio supports healthy aging and cellular health, distributed through e-commerce and retail. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.
Key slides for Niagen Bioscience Inc
Corporate Presentation
Niagen Bioscience Inc
Q4 2024
Niagen Bioscience Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
NAGE
Country
🇺🇸 United States